SC
STRO icon

Stempoint Capital’s Sutro Biopharma STRO Stock Holding History

Stempoint Capital’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$580K Buy
+23,295
New +$421K 0.11% 69

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Stempoint Capital's STRO Position: Q1 2026 in Review

Stempoint Capital opened a new position in Sutro Biopharma (STRO) in Q1 2026: 23,295 shares worth $580K. The stake represents 0.11% of the portfolio and ranks #69 among its holdings.

78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Stempoint Capital held 23,295 shares of Sutro Biopharma worth $580K as of Q1 2026.
  • Sutro Biopharma was a new Stempoint Capital position in Q1 2026.
  • Sutro Biopharma made up 0.11% of Stempoint Capital's portfolio in Q1 2026, its #69 holding.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.